Filing Details
- Accession Number:
- 0001140361-16-058349
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-03-17 19:51:02
- Reporting Period:
- 2016-03-15
- Filing Date:
- 2016-03-17
- Accepted Time:
- 2016-03-17 19:51:02
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 943819 | Resmed Inc | RMD | Surgical & Medical Instruments & Apparatus (3841) | 980152841 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1485164 | J. Michael Farrell | Resmed Inc. 9001 Spectrum Center Blvd San Diego CA 92123 | Chief Executive Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Resmed Common Stock | Acquisiton | 2016-03-15 | 5,975 | $33.70 | 150,852 | No | 4 | M | Direct | |
| Resmed Common Stock | Disposition | 2016-03-15 | 5,975 | $58.57 | 144,877 | No | 4 | S | Direct | |
| Resmed Common Stock | Acquisiton | 2016-03-16 | 8,097 | $0.00 | 152,974 | No | 4 | A | Direct | |
| Resmed Common Stock | Disposition | 2016-03-16 | 4,226 | $0.00 | 148,748 | No | 4 | F | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | A | Direct | |
| No | 4 | F | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Resmed Commmon Stock | ResMed Common Stock Options | Disposition | 2016-03-15 | 5,975 | $0.00 | 5,975 | $33.70 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 45,125 | 2010-11-11 | 2017-11-11 | No | 4 | M | Direct |
Footnotes
- The transaction was conducted under a 10b5-1 Plan as defined under the Securities Exchange Act of 1934, as amended.
- Represents date options first became exercisable. Options vest 1/4 annually.
- Shares acquired on vesting of performance-based restricted stock units. The PSUs were granted March 1, 2013, with a three-year performance period. The shares were earned and vested March 16, 2016, when the ResMed compensation committee certified performance.
- Shares earned, based on performance, at 40% of the target award.
- Disposition to issuer for tax withholding on vesting of performance-based restricted stock units granted March 1, 2013.
Billionaire Hedge Funds
